LEVIN GADI enters BRIACELL THERAPEUTICS CORP. with 2.81K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/1/2022ACC: 0001493152-22-020878
Officer· CFO & Secretary
Since Aug 2022
2.81K
Baseline shares
100% direct
2.81K
Direct ownership
1 position
95K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned2.81K
Total
2.81K direct2.81K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 2.81K | Direct |
| Total | 2.81K | 2.81K direct |
Derivative Holdings2
Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
20K
Shares owned
N/A
Exercise price
4.71
Expiration
—
Exercise window
—
Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
75K
Shares owned
N/A
Exercise price
4.24
Expiration
—
Exercise window
—
Total
Underlying
95K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Option (Right to Buy) Direct | Common Shares | 4.71 | — | — | 20K | N/A |
| Option (Right to Buy) Direct | Common Shares | 4.24 | — | — | 75K | N/A |
| Total | 95K | 0.00 | ||||